Karl Leibinger Medizintechnik GmbH & Co. KG Sustainability Profile
Karl Leibinger Medizintechnik GmbH & Co. KG, commonly known as KLS Martin, is a leading player in the medical technology industry, headquartered in Tuttlingen, Germany. Founded in 1923, the company has established itself as a pioneer in the development of innovative surgical instruments and implants, particularly in the fields of cranio-maxillofacial surgery and orthopaedics. With a strong presence in Europe and expanding operations globally, KLS Martin is renowned for its high-quality products, including advanced surgical systems and customised solutions that enhance surgical precision and patient outcomes. The company’s commitment to research and development has led to numerous milestones, solidifying its position as a trusted partner for healthcare professionals. KLS Martin's dedication to excellence and innovation continues to drive its success in the competitive medical technology landscape.
DitchCarbon Score
How does Karl Leibinger Medizintechnik GmbH & Co. KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Karl Leibinger Medizintechnik GmbH & Co. KG's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Karl Leibinger Medizintechnik GmbH & Co. KG's reported carbon emissions
Karl Leibinger Medizintechnik GmbH & Co. KG, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions data. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, the organisation's climate commitments and initiatives remain unclear. In the context of the medical technology industry, companies are increasingly focusing on sustainability and reducing their carbon footprints. However, without specific data or commitments from Karl Leibinger Medizintechnik, it is challenging to assess their environmental impact or progress in this area. Overall, the lack of emissions data and reduction initiatives suggests that the company may need to enhance its transparency and commitment to climate action in line with industry standards.
How Carbon Intensive is Karl Leibinger Medizintechnik GmbH & Co. KG's Industry?
How Carbon Intensive is Karl Leibinger Medizintechnik GmbH & Co. KG's Location?
Karl Leibinger Medizintechnik GmbH & Co. KG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Karl Leibinger Medizintechnik GmbH & Co. KG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
